LongView Wealth Management’s AbbVie ABBV Stock Holding History

LongView Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.71M	Sell	6,802 -1,079	-14%	-$232K	0.44%	55
2026 Q1	$1.66M	Buy	7,881 +18	+0.2%	+$3.99K	0.42%	56
2025 Q4	$1.73M	Buy	7,863 +1,474	+23%	+$336K	0.42%	55
2025 Q3	$1.48M	Sell	6,389 -151	-2%	-$30.7K	0.4%	56
2025 Q2	$1.21M	Sell	6,540 -149	-2%	-$27.7K	0.37%	61
2025 Q1	$1.4M	Sell	6,689 -88	-1%	-$17.1K	0.42%	54
2024 Q4	$1.2M	Sell	6,777 -314	-4%	-$57.7K	0.37%	63
2024 Q3	$1.4M	Buy	7,091 +9	+0.1%	+$1.68K	0.45%	54
2024 Q2	$1.21M	Buy	7,082 +40	+0.6%	+$6.63K	0.45%	51
2024 Q1	$1.28M	Sell	7,042 -660	-9%	-$114K	0.51%	47
2023 Q4	$1.25M	Buy	+7,702	New	+$1.12M	0.56%	44

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LongView Wealth Management's ABBV Position: Q2 2026 in Review

LongView Wealth Management reduced its AbbVie (ABBV) stake by 14% in Q2 2026, selling an estimated $232K and leaving 6,802 shares worth $1.71M. The position accounts for 0.44% of the portfolio, ranked #55.

LongView Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.73M in Q4 2025. 4,207 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

LongView Wealth Management held 6,802 shares of AbbVie worth $1.71M as of Q2 2026.
LongView Wealth Management sold 1,079 AbbVie shares in Q2 2026, an estimated $232K.
AbbVie made up 0.44% of LongView Wealth Management's portfolio in Q2 2026, its #55 holding.
LongView Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
LongView Wealth Management's AbbVie position peaked at $1.73M in Q4 2025.
4,207 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on LongView Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.